Related Experiment Video
Updated: Apr 3, 2026

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
Published on: August 4, 2022
Endocannabinoid signalling in reward and addiction
Loren H Parsons1, Yasmin L Hurd2
1Committee on the Neurobiology of Addictive Disorders, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, California 92037, USA.
Abstract:
Brain endocannabinoid (eCB) signalling influences the motivation for natural rewards (such as palatable food, sexual activity and social interaction) and modulates the rewarding effects of addictive drugs. Pathological forms of natural and drug-induced reward are associated with dysregulated eCB signalling that may derive from pre-existing genetic factors or from prolonged drug exposure. Impaired eCB signalling contributes to dysregulated synaptic plasticity, increased stress responsivity, negative emotional states and cravings that propel addiction. Understanding the contributions of eCB disruptions to behavioural and physiological traits provides insight into the eCB influence on addiction vulnerability.
Related Concept Videos
Drug Abuse and Addiction: Pharmacological Phenomena
Opioid Receptors: Overview
Regulation of Food Intake
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
Intracellular Signaling Cascades
Analgesia and Pain Management

